[Federal Register Volume 71, Number 65 (Wednesday, April 5, 2006)]
[Notices]
[Page 17104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-4932]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Disease, Disability, and Injury Prevention and Control Special 
Emphasis Panels (SEP): Development and Testing of New Medications for 
the Treatment of Emerging Infectious Diseases, Request for Applications 
(RFA) Number CI06-006

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following meeting:

    Name: Disease, Disability, and Injury Prevention and Control 
Special Emphasis Panel (SEP): Development and Testing of New 
Medications for the Treatment of Emerging Infectious Diseases, RFA 
Number CI06-006.
    Time and Date: 12 p.m.-4 p.m., April 25, 2006 (Closed).
    Place: Teleconference.
    Status: The meeting will be closed to the public in accordance 
with provisions set forth in Section 552b(c)(4) and (6), Title 5 
U.S.C., and the Determination of the Director, Management Analysis 
and Services Office, CDC, pursuant to Public Law 92-463.
    Matters to be Discussed: The meeting will include the review, 
discussion, and evaluation of applications received in response to: 
Development and Testing of New Medications for the Treatment of 
Emerging Infectious Diseases, RFA Number CI06-006.
    For Further Information Contact: Christine Morrison, PhD, 
Scientific Review Administrator, Office of Public Health Research, 
Centers for Disease Control and Prevention, 1600 Clifton Road, NE., 
Mailstop D-72, Atlanta, GA 30333, Telephone 404-639-3098.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.


    Dated: March 30, 2006.
Alvin Hall,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
 [FR Doc. E6-4932 Filed 4-4-06; 8:45 am]
BILLING CODE 4163-18-P